InPACT International Penile Advanced Cancer Trial (International Rare Cancers Initiative study)

Sponsor:

ECOG-ACRIN Cancer Research Group

Sponsor Study ID:

EA8134

CTO #:

103220

NCT Number:

NCT02305654

Phase:

III

Protocol Type:

Treatment

Age Group:

Adults

Disease Sites:

Other Male Genital

Study Objectives:

This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a series of questions that routinely arise in the sequencing of treatment. The study design has evolved from lengthy international consultation that has enabled us to build consensus over which questions arise from current knowledge and practice. It will enable potential randomisation for the majority of patients with inguinal lymph node metastases and will provide data to inform future clinical decisions.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)